Clofazimine as a drug for TB in the mouse model

Date:

January 29, 2015 at 12:15pm - 1:20pm

In this lecture, Dr. Jaques Grosset describes his effort to reproduce results of a multi-drug TB treatment regimen that utilized Clofazimine for treating patients with drug resistance, using the mouse model.

Video/Audio/Slides

Audio-only/Slides

Projects

Assessing the social value of novel regimens...

We are collaborating with investigators from the Berman Bioethics Institute to develop novel techniques for economic evaluation...

Read More

A Comprehensive Snapshot of Tuberculosis...

This study aims to find all cases of TB within an urban Ugandan community of 50,000 people and to characterize both the...

Read More

ICOHRTA Training Program (Fogarty)

International Clinical, Operational, and Health Services Research Award (ICOHRTA) training program. A training program that...

Read More

Modeling to improve TB decision-making in the...

We are part of a large consortium that is constructing epidemic and economic models of TB and HIV in collaboration with the U.S....

Read More

ACTG trial A5343

Phase 2 safety study of bedaquiline and delamanid for the treatment of MDR-TB in South Africa

Read More